Dae Han New Pharm Co., Ltd. operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Dae Han New Pharm Co., Ltd. with three other
companies in this sector in South Korea:
Hanall Biopharma Company Limited
sales of 80.02 billion Korean Won [US$71.46 million]
of which 100%
was Medicinals and Bontanicals),
Nutri Biotech Co Ltd
(77.52 billion Korean Won [US$69.22 million]
Theragen Etex Co Limited
(98.88 billion Korean Won [US$88.30 million]
Dae Han New Pharm Co., Ltd. reported sales of 90.23 billion Korean Won (US$80.58 million)
December of 2015.
increase of 25.4%
versus 2014, when the company's sales were 71.94 billion Korean Won.
This was the fourth straight year of sales growth at Dae Han New Pharm Co., Ltd..